Bisphosphonates and risk of cancers: a systematic review and meta-analysis

• Published in: British journal of cancer Vol. 123; no. 10; pp. 1570 - 1581
• Main Authors: Li, Yuan-Yuan, Gao, Li-Jie, Zhang, Yu-Xue, Liu, Shu-Juan, Cheng, Shuo, Liu, Yu-Peng, Jia, Cun-Xian
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 10.11.2020; Nature Publishing Group
• Subjects: 631/67/2195; 692/699/67/2195; Aged; Biomedical and Life Sciences; Biomedicine; Bisphosphonates; Breast cancer; Breast Neoplasms - epidemiology; Breast Neoplasms - etiology; Cancer Research; Colonic Neoplasms - epidemiology; Colonic Neoplasms - etiology; Colorectal cancer; Colorectal carcinoma; Colorectal Neoplasms - epidemiology; Colorectal Neoplasms - etiology; Cytoprotection - drug effects; Diphosphonates - chemistry; Diphosphonates - therapeutic use; Drug Resistance; Endometrial cancer; Endometrial Neoplasms - epidemiology; Endometrial Neoplasms - etiology; Endometrium; Epidemiology; Female; Humans; Liver cancer; Liver Neoplasms - epidemiology; Liver Neoplasms - etiology; Male; Meta-analysis; Middle Aged; Molecular Medicine; Neoplasms - epidemiology; Neoplasms - etiology; Nitrogen; Nitrogen Compounds - chemistry; Nitrogen Compounds - therapeutic use; Oncology; Pancreas; Pancreatic cancer; Pancreatic Neoplasms - epidemiology; Pancreatic Neoplasms - etiology; Prevalence; Risk Factors
• DOI: 10.1038/s41416-020-01043-9
• ISSN: 0007-0920; 1532-1827

Background It is unclear whether bisphosphonates are associated with risk of cancers. Therefore, this meta-analysis aimed to evaluate the effect of bisphosphonates on overall cancers. Methods A search in Pubmed, Embase, Cochrane Library and Web of Science databases was conducted, from the inception date of each resource to September 26, 2019. The summarised effect estimates with 95% CIs were calculated using a random-effect model. Heterogeneity and publication bias were explored. Results Thirty-four articles were included in this study (4,508,261 participants; 403,196 cases). The results revealed that bisphosphonates significantly decreased the risk of colorectal cancer (RR = 0.89, 95% CI: 0.81–0.98), breast cancer (RR = 0.87, 95% CI: 0.82–0.93) and endometrial cancer (RR = 0.75, 95% CI: 0.61–0.94), but no significant association was observed in all-cause cancer. Furthermore, nitrogen-containing bisphosphonates only had protective effects both on breast cancer (RR = 0.94, 95% CI: 0.90–0.99) and endometrial cancer (RR = 0.70, 95% CI: 0.54–0.92). Non-nitrogen-containing bisphosphonates tended to increase the risk of liver cancer (RR = 2.14, 95% CI: 1.23–3.72) and pancreas cancer (RR = 1.75, 95% CI: 1.32–2.33). Conclusion Bisphosphonates are significantly associated with risk reduction of colorectal, breast and endometrial cancer, especially nitrogen-containing bisphosphonates. It should be noted that non-nitrogen-containing bisphosphonates might increase the risk of liver and pancreas cancer. Large prospective cohort studies are needed to find the causal association between bisphosphonates and risk of cancers.